360
Participants
Start Date
August 31, 2010
Primary Completion Date
May 31, 2013
Study Completion Date
June 30, 2013
Placebo
Participants will be randomized to receive Low dose Dopamine or placebo plus optimal diuretic or Low dose Nesiritide or placebo plus optimal diuretic.
Nesiritide
"Active Comparator: Low Dose Nesiritide~Participants randomized to the low dose nesiritide arm will receive nesiritide of 0.005 ug/kg/min or placebo during the first 72 hours in the trial."
Dopamine
Participants randomized to the low dose dopamine arm will receive dopamine of 2ug/kg/min or placebo during the first 72 hours in the trial.
Duke University Medical Center, Durham
Minnesota Heart Failure Network, Minneapolis
Mayo Clinic, Rochester
Baylor College of Medicine, Houston
University of Utah Health Sciences Center, Murry
Brigham and Women's Hospital, Boston
University of Vermont- Fletcher Allen Health Care, Burlington
Montreal Heart Institute, Montreal
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Duke University
OTHER